Professor of Dermatology, Massachusetts General Hospital

Dermatology

Arthur Sober works in the field of Dermatology. He studied medicine at George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care He received 3 awards: "Super Doctor", "Top MD" and "Fellow (FAAD)". Arthur J. Sober is also a published physician. He has 49 paper published. The most recent paper is: Translating psoriasis guidelines into practice: Important gaps revealed. He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Translating psoriasis guidelines into practice: Important gaps revealed.
• Early detection of Melanoma: Reviewing the ABCDEs.
• Outcome of patients with de novo versus nevus-associated Melanoma.
• The utility of re-excising mildly and moderately dysplastic nevi: A retrospective analysis.
• Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel Cell carcinoma.
• Specializing in Accountability: Strategies to Prepare a Subspecialty Workforce for Care Delivery Redesign.
• Melanoma Epidemic: An Analysis of Six Decades of Data From the Connecticut Tumor Registry.
• The distribution of microscopic Melanoma metastases in sentinel lymph nodes: implications for pathology protocols.
• Prognostic factors for Melanoma.
• Histologically challenging melanocytic tumors referred to a tertiary care pigmented Lesion clinic.
• Guidelines of care for the management of primary cutaneous Melanoma.
• A new American Joint Committee on Cancer staging system for cutaneous squamous Cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics.
• Urgent access to a specialty care Melanoma clinic is associated with a higher rate of Melanoma detection.
• Pathologic nodal evaluation improves prognostic accuracy in Merkel Cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.
• Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.
• Improvements in the staging of cutaneous squamous-Cell carcinoma in the 7th edition of the AJCC Cancer Staging Manual.
• Sentinel lymph node biopsy and Melanoma: 2010 update Part II.
• Sentinel lymph node biopsy and Melanoma: 2010 update Part I.
• Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary Melanoma using MelaPRO.
• Final version of 2009 AJCC Melanoma staging and classification.
• The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of Cancer death.
• Why Cancer at the primary site and in the lymph nodes contributes to the risk of Cancer death.
• How Cancer at the primary site and in the lymph nodes contributes to the risk of Cancer death.
• Melanoma in the young: differences and similarities with adult Melanoma: a case-matched controlled analysis.
• Association between the anatomic distribution of Melanoma and sex.
• Method of biopsy and incidence of positive margins in primary Melanoma.
• Willingness-to-pay stated preferences for telemedicine versus in-person visits in patients with a history of psoriasis or Melanoma.
• A randomized trial to improve early detection and prevention practices among siblings of Melanoma patients.
• An erythematous and pigmented Lesion of the abdomen--quiz case.
• Immunization using autologous dendritic Cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity.
• Biology of desmoplastic Melanoma: a case-control comparison with other Melanomas.
• Melanoma treatment update.
• Congenital melanocytic nevi: clinical and histopathologic features, risk of Melanoma, and clinical management.
• Prolonged evolution of a lentigo maligna.
• Management of cutaneous Melanoma.
• A nonepidermal, primary malignant Melanoma arising in a giant congenital melanocytic nevus 40 years after partial surgical removal.
• Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous Melanoma always necessary?
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2004. A 48-year-old woman with multiple pigmented Lesions and a person...
• Melanoma before and after Thomas B. Fitzpatrick.
• Early detection of asymptomatic pulmonary Melanoma metastases by routine chest radiographs is not associated with improved survival.
• Skin cancer prevention and detection practices among siblings of patients with melanoma.
• The first 15 years of the American Academy of Dermatology Skin cancer screening programs: 1985-1999.
• Prevalence of melanoma clinically resembling seborrheic Keratosis: analysis of 9204 cases.
• Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreen...
• Melanoma incidence trends.
• Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic Cell vaccine for metastatic melanoma.
• Diagnosis and management of nevi and cutaneous Melanoma in infants and children.
• A single-institution case series of patients with cutaneous Melanoma and non-Hodgkin's lymphoma.

Schools

---

• George Washington University School Of Medicine

• Beth Israel Hospital

• Massachusetts General Hospital

• Rb Brigham Hospital

Procedures Preformed

---

• Destruction of Benign Skin Lesion

Conditions Treated

---

• Actinic Keratosis
• Athlete's Foot
• Basal Cell Carcinoma
• Benign Skin Lesion
• View All

Doctors Specialties

---

• Dermatology
• Internal Medicine

Accepted Insurances

---

Awards

---

• Super Doctor
• Top MD
• Fellow (FAAD)

Education

---

• Massachusetts General Hospital
• Beth Israel Deaconess Medical Center
• George Washington University School of Medicine

Hospital

---

• Massachusetts General Hospital

Drug Facts

---

NPI NUMBER		1194707489
NPPES Provider LastName		SOBER
NPPES Provider FirstName		ARTHUR
NPPES Provider ZIPCode		021142517
NPPES Provider State		MA
Specialty Description		Dermatology
Total Claim Count		150.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1194707489
Last Name Of The Provider	SOBER
First Name Of The Provider	ARTHUR
View All

Similar Doctors

---

	Dr. Sarina B. Elmariah, MD This Doctor is OpenDoctor Recommended.
	Dr. Laura B. Myers, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard R. Anderson, MD This Doctor is OpenDoctor Recommended.
	Dr. Maria Beatrice A. Palli, MD This Doctor is OpenDoctor Recommended.
	Dr. Dieter Manstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Bobby Y. Reddy, MD
	Dr. Lixia Zhao, MD This Doctor is OpenDoctor Recommended.
	Dr. John B. Korman, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer M. Hunter-Yates, MD
	Dr. Mathew M. Avram, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jeremy M. Robbins, MD This Doctor is OpenDoctor Recommended.
	Dr. Mitchell H. Rubenstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Ronald A. Arky, MD This Doctor is OpenDoctor Recommended.
	Dr. Leslie C. Lucchina, MD This Doctor is OpenDoctor Recommended.
	Dr. Tejal K. Gandhi, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Daniel G. Steinberg, MD This Doctor is OpenDoctor Recommended.
	Dr. George A. Hasiotis, MD This Doctor is OpenDoctor Recommended.
	Dr. Pooja R. Raval, MD This Doctor is OpenDoctor Recommended.
	Dr. Qiyue Hu, MD This Doctor is OpenDoctor Recommended.
	Dr. Laura Wung, MD This Doctor is OpenDoctor Recommended.
	Dr. Abdulaziz Madani, MD
	Dr. Lana N. Kashlan, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah J. Hahn, MD
	Dr. Debjani Sahni, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog